#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adult T-cell lymphoma/leukaemia refractory Cystic fibrosis respiratory infection suppression Cystic fibrosis lung Factor IX deficiency Cryoglobulinaemia Uveitis White matter lesion Ependymoma Heavy menstrual bleeding Antiphospholipid antibodies T-cell lymphoma Prostate cancer Fatty acid oxidation disorder Non-small cell lung cancer recurrent Haemophilia B with anti factor IX More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Basic Information Focal segmental glomerulosclerosis Cytokine release syndrome Mast cell activation syndrome – Basic Information Rhabdomyosarcoma – Basic Information Burkitt’s lymphoma – Diagnostics Indolent systemic mastocytosis – Treatment Glycogen storage disease type I – Treatment Cerebral arteriovenous malformation haemorrhagic Sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sertraline Hydrochloride Thiamine Nitrate Bp Sugammadex Donanemab LTI-03 Varenicline Piperacillin ULVIPRUBART Eribulin Mesylate Rtp-026 Sodium Baloxavir Marboxil Remifentanil Deoxyribonucleic Acid Domvanalimab Ertapenem Sodium Fondaparinux Sodium Mepolizumab Clazakizumab Cdr132L Sodium Potato Starch More therapies…

    Learn about Your Condition

    Mucosal inflammation Supraventricular tachycardia Ewing's sarcoma metastatic Type 1 diabetes mellitus Arthritis infective Laryngeal leukoplakia Vaginal cancer Monkeypox Solitary fibrous tumour Persistent depressive disorder Bladder cancer stage II Meningorrhagia Peripheral ischaemia Embolism Leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hyperinsulinism

  • Study on Ersodetug for Patients with Uncontrolled Low Blood Sugar Due to Tumor-Related High Insulin Levels

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anti-(Insulin Receptor) Human Monoclonal Antibody
    France The Netherlands

  • Study on the Safety and Effects of Efpegerglucagon in Children Aged 2 and Older with Congenital Hyperinsulinism

    Recruiting

    2 1 1
    Investigated Drugs:
    • Efpegerglucagon
    Germany

  • Study on RZ358 for Treating Congenital Hyperinsulinism in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Hyperinsulinaemic hypoglycaemia
    • Hyperinsulinism
    Investigated Drugs:
    • Anti-(Insulin Receptor) Human Monoclonal Antibody
    Bulgaria Denmark France Germany Greece Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!